Our paper peeling back the pharmacology behind the new antipsychotic SEP-856 (Ulotaront) can be accessed here
Per Svenningsson elected as a member of Academia Europaea
Link to Per’s page can be found here
25.05.2022 – PhD defence of Panagiota Tsitsi
13.05.2022 – Mattias Andréasson defends his PhD
Right: Per and Martin Paucar together with thesis opponent Prof. Claudia Trenkwalder
11.05.2022 – Public defence of Ioannis Mantas
Lunch at lab day
Per Svenningsson named as a member of the Molecular Psychiatry Editorial board
Per Svenningsson is now a board member of the editorial team for Molecular Psychiatry. Visit the following link to see all members: https://www.nature.com/mp/editors/editorial-board
Ceremony Arvid Carlsson Foundation award
Nobel Prize in Physiology or Medicine awarded to David Julius and Ardem Patapoutian for their discoveries of receptors for temperature and touch
As a member of the Nobel Committee, Per Svenningsson was very actively involved with this year’s Nobel Prize in Physiology or Medicine.
Our research on how ketamine prevents depression was published on Molecular Psychiatry
The discovery that the anaesthetic ketamine can help people with severe depression has raised hopes of finding new treatment options for the disease. Researchers at Karolinska Institutet have now identified novel mechanistic insights how the drug exerts its antidepressant effect. The findings have been published in the journal Molecular Psychiatry.
https://news.ki.se/new-findings-on-how-ketamine-prevents-depression